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Cardiovascular disease (CVD) is the leading cause of mortality worldwide claiming almost
17. 9 million deaths annually. A primary cause is atherosclerosis within the coronary
arteries, which restricts blood flow to the heart muscle resulting in myocardial infarction
(MI) and cardiac cell death. Despite substantial progress in the management of coronary
heart disease (CHD), there is still a significant number of patients developing chronic heart
failure post-MI. Recent research has been focused on promoting neovascularisation
post-MI with the ultimate goal being to reduce the extent of injury and improve function
in the failing myocardium. Cardiac cell transplantation studies in pre-clinical models have
shown improvement in cardiac function; nonetheless, poor retention of the cells has
indicated a paracrine mechanism for the observed improvement. Cell communication
in a paracrine manner is controlled by various mechanisms, including extracellular
vesicles (EVs). EVs have emerged as novel regulators of intercellular communication,
by transferring molecules able to influence molecular pathways in the recipient cell.
Several studies have demonstrated the ability of EVs to stimulate angiogenesis by
transferring microRNA (miRNA, miR) molecules to endothelial cells (ECs). In this review,
we describe the process of neovascularisation and current developments in modulating
neovascularisation in the heart using miRNAs and EV-bound miRNAs. Furthermore, we
critically evaluate methods used in cell culture, EV isolation and administration.
Keywords: extracellular vesicles (EV), microRNA (miR), neovascularisation, angiogenesis, cardiac, myocardial
infarct, exosome (EXO), regeneration
INTRODUCTION
CVD is the leading cause of mortality worldwide with the World Health Organization (WHO)
reporting that in 2016, 17.9 million people died from CVDs. Of those deaths, an estimated
7.4 million were attributed to CHD alone (WHO Cardiovascular diseases CVDs, 2017). CHD
is characterised by narrowing of the coronary arteries due to the gradual formation and the
subsequent rupture of plaque within the vessel walls. Blockage of these arteries results in
oxygen and nutrient deprivation of the downstream tissue. Consequently, ischaemic damage and
cardiomyocyte death occur in the affected region of the heart, a phenomenon known as MI
(Thygesen et al., 2019). Various methods, including stem cell (SC) injection, growth factor (GF)
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delivery, and miRNA treatment, have been proposed to
reduce cardiomyocyte death; nonetheless, several limitations
have restricted their use. The idea of restoring the lost
myocardium was proven to be inefficient since adult mammal
cardiomyocytes are terminally differentiated and in contrast
to other vertebrate species, such as zebrafish, adult mammal
cardiac regenerative capacity is limited (Ye et al., 2018).
For this reason, SC injection was proposed as a promising
strategy for cardiac repair. The initial hypothesis was that
transplanted SCs would differentiate into cardiomyocytes,
integrate into the host myocardium, and augment cardiac
function through synchronised electromechanical coupling
(Garbern and Lee, 2013; Lemcke et al., 2018). Despite some
encouraging results, this approach has proven to be largely
unsuccessful to date due to several issues, including poor
engraftment, immune rejection, genetic instability, and possible
teratocarcinoma formation. Importantly, the engrafted cells have
also demonstrated relatively poor electrical coupling with the
host myocardium, leading to the development of additional
safety issues (Liu et al., 2018; Menasché et al., 2018; Romagnuolo
et al., 2019). Recently, Vagnozzi et al. (2020), showed that the
improvement in cardiac function following SC transplantation
may be due to an acute inflammatory wound-healing response,
rather than incorporation of delivered cells or production of
new cardiomyocytes.
Aiming to improve recovery after MI and, therefore, rescue
as many cardiomyocytes as possible, research interest is focused
on promoting neovascularisation to create newmyocardial blood
vessel networks. Paracrine cell communication plays a critical
role in the control of this process (Gnecchi et al., 2008; Mirotsou
et al., 2011; Hodgkinson et al., 2016). Cell communication in a
paracrine manner is regulated by several mechanisms, including
EVs. EVs carry and transfer various bioactive molecules, such
as small non-coding RNAs, proteins, and lipids, that moderate
signalling pathways in the recipient cells. These functional
contents depend on several factors, including the cellular origin
and the (patho)physiological state of the cells during EV packing
and secretion (Raposo and Stoorvogel, 2013). Recently, EV-
miRNAs have gained immense interest in the control of cell
behaviour in the recipient cells. miRNAs are small non-coding
RNAs of approximately 22 nucleotides and have been recognised
as critical regulators of gene expression. While most miRNAs
regulate gene expression by binding to the 3
′
untranslated region
of their messenger RNA (mRNA) target, there are also sporadic
reports of miRNAs that inhibit protein translation by binding
to the 5
′
untranslated region of their target. Under certain
conditions, miRNAs can also control transcription or activate
translation (O’Brien et al., 2018). Nonetheless, there is great
controversy regarding the functional relevance of miRNAs in
EVs. Several reports suggest that the majority of extracellular
miRNAs are protected from plasma ribonucleases by forming
complexes with proteins, such as Ago2 and that only a few
copies of each miRNA are found in EVs (Arroyo et al., 2011;
Chevillet et al., 2014). Moreover, in a non-peer-reviewed study, it
was recently argued that miRNAs are not effectively delivered to
target cells in a functional manner (Albanese et al., 2020). On the
other hand, numerous studies have demonstrated that protected
from plasma ribonucleases by their EV carriers, functional
miRNAs can be delivered and internalised into recipient cells,
acting as novel regulators of gene expression by inhibiting
their targets (Johnson et al., 2019; Qiao et al., 2019; Cavallari
et al., 2020). Despite this controversy, preclinical studies have
demonstrated that EVs hold promise in the regulation of complex
processes such as neovascularisation. In this review, we describe
the process of neovascularisation and current developments in
modulating neovascularisation in the heart using miRNAs and
EV-bound miRNAs. Furthermore, we critically evaluate methods
used in cell culture, EV isolation and routes of EV administration.
POST-ISCHAEMIC NEOVASCULARISATION
After the onset of myocardial ischaemia due to coronary artery
occlusion, there is an inadequate blood supply to the heart
muscle, which results in a pathological change in electrical,
contractile or biochemical function of the heart (Grover,
1995). Therefore, post-ischaemic neovascularisation is essential
to support the metabolic needs of cardiac cell populations.
Angiogenesis and arteriogenesis are regulated by distinct, but
partially overlapping, cellular and molecular mechanisms and
are responsible for tissue repair and remodelling in acute and
chronic ischaemic diseases (Persson and Buschmann, 2011).
Angiogenesis refers to the formation of new blood vessels from
pre-existing vessels and can be classified as intussusceptive or
sprouting angiogenesis (Caduff et al., 1986; Burri and Tarek,
1990; Risau, 1997). Intussusceptive angiogenesis is a dynamic
splitting process in which elements of interstitial tissues invade
existing blood vessels forming a cylindrical microstructure that
spans the lumen of capillaries and small vessels (Short, 1950;
Caduff et al., 1986).
As implied by its name, sprouting angiogenesis is
characterised by EC sprouts, which usually grow toward an
angiogenic stimulus. Hypoxia is one of the key drivers of
this process. The primary mechanism of hypoxia-induced
neovascularisation involves an increase in hypoxia-inducible
factor (HIF-1a) levels (Figure 1). When oxygen-sensing
mechanisms detect low oxygen levels, new blood vessels are
required to satisfy the metabolic requirements of parenchymal
cells. Most of these cells respond to hypoxic stimuli by secreting
a critical proangiogenic growth factor, vascular endothelial
growth factor (VEGF-A). A particular type of EC, known as
tip cells, leads sprouting angiogenesis (Gerhardt et al., 2003).
The filopodia of endothelial tip cells are endowed with VEGF-
A receptors (VEGFR2) that allow them to sense changes in
VEGF-A concentrations and drive them to align with the VEGF
gradient. Neighbouring cells, known as stalk cells, divide as they
follow behind a tip cell, elongating the new vessel. Maturation
and stabilisation of the vessels involve the recruitment of
pericytes and ECM deposition along with mechanical stimuli
(Stratman and Davis, 2012). This process is highly conserved and
regulated by very specific molecular pathways, such as the Notch
signalling pathway. In response to VEGF-A, the expression of the
ligand Dll4 increases on the surface of tip cells. As a result, these
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FIGURE 1 | Schematic representation of post-ischaemic neovascularisation. (1a) Under normoxic conditions, DLL4-Notch-1 signalling is balanced in ECs. (1b) Under
normoxic conditions, small collateral arterioles may connect main arteries. (2a) Low O2 conditions increase HIF-1a levels, which in turn stimulates the
(Continued)
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FIGURE 1 | expression of VEGF-A (represented as small blue dots). In response to VEGF-A, Dll4 expression increases on the surface of tip cells (purple cell). Dll4
receptors on tip cells bind to Notch receptors on the surface of stalk cells (yellow cells) activating Dll4/Notch signalling pathway. Dll4—Notch-1 signalling directs ECs
into migrating tip or proliferating stalk cells. In response to VEGF-A, VEGFR expression increases on the filopodia of tip cells (represented as protrusions on the tip
cell), which then migrate towards VEGF-A with the stalk cells proliferating behind them. This results in the expansion of the vessel lumen and the formation of sprouts
on the vessel wall (angiogenesis). (2b) When a coronary artery is occluded due to the formation of plaque within the arterial wall, there is increased shear stress in the
collateral arterioles. In response to shear stress, collateral arteriole diameter increases in size (arteriogenesis).
ligands bind to Notch1 receptors of adjacent cells and activate
Notch signalling pathway that suppresses tip cell fate and induces
the stalk cell phenotype in these cells (Del Toro et al., 2010).
While angiogenesis is stimulated by low-oxygen
concentrations and leads to the creation of new capillaries,
arteriogenesis is induced by physical forces; mainly fluid shear
stress. Arteriogenesis is an adaptive response to transient,
repetitive occlusion of a large main artery and is characterised
by an enlargement of the collateral arterioles (Figure 1). Once
a main artery is occluded the arterial pressure behind the
stenosis site decreases, and the blood is redistributed via the
collateral arterioles. Thus, collateral arterioles now connect a
high-pressure with a low-pressure region (Schaper and Pasyk,
1976). While hypoxia-induced pathways, as well as alterations in
haemodynamic forces of the vascular wall, have been proposed
as critical regulators of vessel growth after an ischaemic event,
emerging evidence supports the idea that tissue-resident EPCs
may also be involved in cardiac neovascularisation post-
ischaemia (Fujisawa et al., 2019). A better understanding of
the cellular frameworks and molecular mechanisms that drive
these processes is crucial for the development of new therapeutic
neovascularisation strategies.
The use of animal models is essential for a better
understanding of the neovascularisation process post-MI at
a cellular level. Aiming to identify the mechanism of EC
proliferation post-ischaemia, Manavski et al. (2018), utilised
Confetti fl/wild type (wt) cadherin 5 (Cdh5)- CreERT2 mice
and revealed that ischaemia-induced vascularisation post-acute
myocardial infarction (AMI) is mediated by clonally expanded
ECs. At day 7 post-AMI 28% of the cardiac sections showed
significant clonal expansion of Cdh5-expressing ECs, and this
was increased to 33% on day 14. Since Cdh5 is also expressed
in bone marrow, the origin of these clonally expanded cells
remained inconclusive. Recently, Li et al. (2019) utilised a Pdgfb-
iCreER -R26R-Brainbow2.1mouse. In this system, the expression
of Cre is driven by a Pdgfb promoter, which is specific to ECs
(Claxton et al., 2008). Using this mouse, they demonstrated
that vessel formation and clonal expansion of cardiac ECs was
mediated by a subpopulation of resident cardiac ECs with
progenitor-like properties.
Genetic lineage tracing has significantly improved our
understanding of the neovascularisation process in the post-
ischaemic heart. Nonetheless, cardiac neovascularisation
potential is limited and does not appear to effectively promote
myocardial regeneration. Recently, Kocijan et al. (2020), used
an Apln-CreER;R26mT/mG mouse model to compare the
angiogenic potential of the heart and skeletal muscle. Apln
is highly expressed in ECs during embryonic development
and is down-regulated in adulthood. However, in response
to hypoxia, under tissue ischaemia or in the context of a
tumour, the expression of Apln is reactivated, particularly in
tip cells. Using this system, the authors showed that different
pro-angiogenic stimuli activated Apln in skeletal muscle,
resulting in angiogenic sprouts that could be incorporated into
arteries. In the heart, however, Apln+ cells failed to give rise
to new vessels. To confirm these data, the authors implanted
cancer cells in different organs and showed that the angiogenic
response in the heart was reduced. These data confirm that the
inherent angiogenic response of the cardiac muscle is limited,
emphasising the need for new therapeutic approaches to promote
endogenous neovascularisation.
MicroRNAs in Therapeutic
Neovascularisation
Over the past few years, miRNAs have gained widespread
attention for their role in vascular health and disease, including
in neovascularisation. MiRNAs are small (18–22 nucleotide,
nt) endogenous non-coding RNA molecules that negatively
regulate gene expression by targeting specific mRNAs. Most
target sites on mRNAs only share a partial complementarity
with their corresponding miRNAs, and thus, a single miRNA
can target multiple mRNAs, contributing to biological and
pathophysiological processes (Huntzinger and Izaurralde, 2011).
Emerging evidence suggests that miRNAs are critical
regulators of both adaptive andmaladaptive vascular remodelling
and angiogenesis. Table 1 contains a list of all known miRNAs
that play a role in cardiovascular neovascularisation as well as
their experimentally confirmed targets. Some of these have been
extensively studied. MiR-126, for instance, is one of the most
abundantly expressed miRNAs in ECs and has a prominent role
in controlling angiogenesis by repressing negative regulators
of the VEGF pathway, such as the Sprouty-related protein
SPRED1 and phosphoinositol-3 kinase regulatory subunit 2
(PIK3R2/p85-beta) (Fish et al., 2008; Wang et al., 2008; Schober
et al., 2014). Wang et al. (2008), showed that targeted deletion
of miR-126 in mice leads to leaky vessels, haemorrhage and
embryonic lethality due to defective vascular integrity. Half of
the animals survived 1 week post-MI, while almost all died within
3 weeks post-MI. Another miRNA with angiogenic properties
is miR-210. MiR-210 upregulation is a principal element of EC
response to hypoxia (Fasanaro et al., 2009). Hu et al. (2010),
demonstrated that overexpression of miRNA-210 post-MI in
mice increased post-ischaemic neovascularisation by inhibiting
ephrin-A3 and improved cardiac function 8 weeks post-MI.
miR-23-24-27 cluster has also been reported to play a critical role
in the regulation of neovascularisation. Knock-out of miR-27b,
a component of this cluster impaired capillary branching in
zebrafish embryos by targeting Dll4 and Sprouty (Spry)-2
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TABLE 1 | miRNAs playing a role in cardiovascular neovascularisation.
miRNA Model Effect Experimentally confirmed
molecular targets
References
miRNAs THAT IMPROVE NEOVASCULARISATION
miR-
10a/10b
miR-10a and miR-10b deficient & WT zebrafish
embryos
Impaired blood vessel outgrowth in miR-10a and miR-10b deficient zebrafish
embryos compared with controls
mindbomb E3 ubiquitin
protein ligase 1 (mib1)
Wang et al., 2016
miR-21 Cardiac microvascular endothelial cells (CMVECs)
Sprague-Dawley rats -MI induction by LAD coronary
artery ligation
Chicken chorioallantoic membrane (CAM)
Increased EC tube formation, proliferation and decreased apoptosis post-miR21
overexpression in-vitro. Improved cardiac function post-miR-21 overexpression in
rats. Opposite effects post-miR inhibition in-vivo. Implantation of matrigel plugs
containing miR-21-overexpressing DU145 cancer cells onto the CAM of a chicken
embryo resulted in increased microvessel formation compared to controls
Phosphatase and tensin
homolog (PTEN)
Liu et al., 2011;
Yang et al., 2016
miR-26b HUVECs
Male CD-1 mice-HLI induction post-left femoral
artery ligation
Increased EC proliferation, migration and tube formation post-miR overexpression
in-vitro. Decreased EC proliferation and tube formation post-miR-inhibition in-vitro.
Increased microvessel formation in a Matrigel plug model. Overexpression of miR-26b
in a mouse HLI model improved capillary survival in the ischaemic muscles
PTEN Martello et al.,
2018
miR-23-24-
27 cluster
(miR-23a/b,
miR-27a/b,
miR-27a-
3p)
HUVECs
EC spheroids
miR-27b knock-out & WT zebrafish embryos
aortic rings from athymic nude mice
FVB mice-HLI induction
C57/Bl6 mice- MI induction by LAD coronary
artery ligation
Decreased EC sprouting in aortic rings ex-vivo post-miR-27b knock-down. Impaired
capillary branching in miR-27b knock-out zebrafish embryos compared with controls.
Increased capillary density and reperfusion post-miR-27b injection in mouse HLI and
MI models compared with controls. Inhibition of miR-23a/b and miR-27a/b in
HUVECs significantly impaired their tube formation ability. Aortic ring treatment with
anti-miR-23 or anti-miR-27 resulted in impaired EC sprouting. Opposite results post
miR-23b and miR-27b overexpression. Overexpression of miR-27a-3p in HUVECs
significantly increased tube formation. Opposite results post-miRNA inhibition.
Overexpression of miR-27a or miR-27b in EC spheroids, resulted in significantly
increased EC sprouting compared to controls. MiR-27a/b inhibition led to opposite
results.
Spry-2 (target of both
miR-23 and miR-27)
Dll4 (target of miR-27b)
Semaphorin 6A (SEMA6A)
(target of both miR-23
and miR-27)
Zhou et al., 2011;
Biyashev et al.,
2012; Veliceasa
et al., 2015; Rao
et al., 2019
miR-29a HUVECs Increased EC tube formation and proliferation post-miR overexpression in-vitro.
Opposite effects were observed post-miR inhibition in EC in-vitro
HMG-Box Transcription
Factor 1 (HBP1)
Yang et al., 2013
miR-30a Transgenic (Tg) friend leukaemia integration 1
transcription factor (fli1): enhanced green fluorescent
protein (EGFP) zebrafish
MiR-30a loss of function decreased arteriolar sprouts compared to controls. miR-30a
gain of function increased arteriolar branching
Dll4 Jiang et al., 2013
miR-31
miR-720
EPCs from patients with CHD
nude mice- HLI induction by ligation of both proximal
and distal portion of the right femoral artery, as well as
the distal portion of saphenous artery
Increased tube formation and migration of EPC post-miR-31/−720 overexpression.
Opposite effects were observed post-miR inhibition. Increased blood flow by
intramuscular injection of EPCs overexpressing miR-31
Thromboxane A2 receptor
(miR-31 target)
Vasohibin-1
(miR-720 target)
Wang et al., 2014
miR-101 HUVECs
Aortic rings from female C57BL/6J mice
Female C57Bl/6J mice- HLI induction by double
ligation of the superficial femoral artery proximal to the
deep femoral artery and distal femoral artery
Increased EC tube formation, proliferation and migration in-vitro post-miR-101
overexpression in-vitro. Increased EC sprouting ex-vivo post-transfection with
mir-101-expressing lentivirus. Increased capillary density and limb perfusion in
miR-101 injected mice compared with controls
CUL 3 Kim et al., 2014
miR-106b-
93-25
cluster
(miR-106b)
Primary bone marrow stromal cells (BMSCs) from
Female WT & miR-106b∼25 knock-out mice
Aortic rings from mir-106b∼25 wild-type or knock-out
mice
Female WT & miR-106b∼25 KO mice—HLI induction
by femoral artery ligation
Increased tube formation ability and survival of BMSCs from WT compared to
BMSCs from miR-106b∼2 knock-out mice. Increased capillary sprouting in WT
compared to miR-106b∼2 knock-out mice. Significantly increased blood flow and
number of lectin-positive capillaries in the WT compared with the KO mice on Day 7 &
Day 14 post-ischaemia
Unknown Semo, 2013
(Continued)
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TABLE 1 | Continued
miRNA Model Effect Experimentally confirmed
molecular targets
References
miR-126 Human aortic endothelial cells (HAECs)
HUVEC
Aortic rings from miR-126−/− mice
Male NMRI nude mice- MI induced by LAD coronary
artery ligation
miR-126−/− mice- MI induced by LAD coronary
artery ligation
Improved HAEC tube formation post-miR-126 transfection in-vitro. Opposite effects
post-miR inhibition in-vitro. Improved HUVEC tube formation
post-miR-126-expressing adenovirus (Ad-miR-126) transfection in-vitro. Opposite
effects were observed post-miR inhibition in-vitro. Impaired EC sprouting in aortic
rings from miR-126−/− mice ex-vivo. Improved cardiac function and capillary density
post-miR-126 mimic injection in NMRI nude mice post-MI. Opposite effects post-miR
inhibition in-vivo. Reduced survival of miR-126−/− mice post-MI (half of the mice died
1week post-MI, and nearly all of them died within 3 weeks post-MI)
SPRED1
PIK3R2
Fish et al., 2008;
Wang et al., 2008;
Jakob et al., 2012
miR-130a HUVECs HUVEC co-transfection with pcDNA3.1-miR-130a and
pcDNA3.1-growth-arrest-homeobox-transcription-factor (GAX) showed that
miR-130a antagonised GAX-induced inhibition of HUVEC tube formation and
migration, increasing tube formation and migration in-vitro. miR-130a inhibitor
reversed antagonism of GAX activity
GAX Chen and Gorski,
2008
miR-132 HUVECs Increased HUVEC tube formation ability and proliferation post-miR overexpression.
Opposite effects were observed post-miR inhibition in EC in-vitro
p120 Ras GTPase activating
protein (p120RasGAP)
Anand et al., 2010
miR-150 HUVECs exposed to oxidised low-density lipoprotein
(LDL)
Apolipoprotein E-deficient (ApoE−/−) mice-HLI
induction by femoral artery ligation
Overexpression of miR-150 rescued the decreased tube formation ability of HUVECs
exposed to LDL. Intramuscular injection of miR-150 mimic increased capillary and
arteriolar (arteriogenesis) densities compared with controls
SRC Kinase Signalling
Inhibitor 1(SRCIN1)
(previously identified target)
Desjarlais et al.,
2017
miR-210 Human umbilical vein endothelial cells (HUVECs),
Aortic rings from female C57BL/6 mice,
miR-210 overexpressing & WT mice subjected to
cardiac ischaemia/reperfusion or permanent LAD
coronary artery ligation
Increased HUVEC tube formation post-miR210 overexpression in-vitro. Opposite
effects were observed post-miR inhibition in-vitro. Increased EC sprouting in aortic
rings from miR-210 overexpressing mouse hearts ex-vivo. Increased reperfusion,
capillary density and improved cardiac function in miR-210 overexpressing mice
compared with controls both after ischaemia-reperfusion and MI induction
Ephrin-A3 Hu et al., 2010;
Arif et al., 2017
14q32
cluster
(miR-329,
miR-487b,
miR-494,
and
miR-495)
Male C57BI/6 mice-HLI induction by electroagulation
of the left femoral artery proximal to the superficial
epigastric arteries (single ligation-model for effective
arteriogenesis), or by electroagulation of the distal
femoral artery proximal to the bifurcation of the
popliteal and saphenous artery (double ligation-model
for severe peripheral arterial disease)
Silencing of miRNAs was induced by gene silencing oligonucleotides (GSO).
Treatment with all 4 GSO improved blood flow recovery post-ischaemia in-vivo.
GSO-495 and GSO-329 treatment increased perfusion 3 days post-ischaemia.
Treatment with GSO-329 only, increased perfusion 7 days post-ischaemia. Increased
collateral artery diameters (arteriogenesis) and capillary densities post-GSO treatment
in mice compared with controls
Myocyte enhancer factor 2A
(MEF2a) (target of miR-329)
FGFR2, VEGF-A, ephrin-2
(targets of miR-494)
Welten et al., 2014
miR-424 HUVECs Increased tube formation, migration and proliferation of EC in-vitro post-miRNA
overexpression. Opposite effects were observed post-miR inhibition in EC in-vitro
Cullin 2 (CUL2) Ghosh et al., 2010
miR-503 HUVECs
Human microvascular endothelial cells (HMVECs)
Increased tube formation and migration of EC in-vitro post-miRNA overexpression.
Opposite results were observed post-miR inhibition in EC in-vitro
Cyclin E1 (CCNE1)
Cell division cycle
25A (cdc25A)
Caporali et al.,
2011
let-7f HUVECs Decreased tube formation and migration of EC in-vitro post-miRNA inhibition Unknown Kuehbacher et al.,
2007
miRNAs THAT INHIBIT NEOVASCULARISATION
miR-15a/
miR-16-1
cluster
(miR-15a,
miR-16)
HUVECs
EC-selective MiR-15a Transgenic (EC-miR-15a TG) &
WT mice- HLI induction by femoral artery ligation
Male CD1 mice- LI induction by left femoral
artery ligation
Increased HUVEC tube formation and migration post-miR inhibition in-vitro. Opposite
results post-miR-overexpression in-vitro. Decreased number of capillaries and blood
perfusion in EC-miR-15a TG mice compared with controls. Inhibition of miR-15a/16
in mice post HLI improved capillary density and blood perfusion
FGF2
VEGF
Yin et al., 2012;
Besnier et al.,
2019
(Continued)
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TABLE 1 | Continued
miRNA Model Effect Experimentally confirmed
molecular targets
References
miR-15b-5p HUVEC
Male C57BL/6 mice- HLI induction by left femoral
artery ligation
Decreased HUVEC tube proliferation and migration post-miR overexpression in-vitro.
Decreased blood flow recovery, capillary and arterial density in HLI mice
post-miR-15b-5p overexpression
AKT Serine/Threonine
Kinase 3 (AKT3)
Zhu et al., 2017
miR-16
miR-426
HUVECs Decreased EC tube formation and migration post-miR overexpression in-vitro VEGF receptor-2 (VEGFR2)
(target of both miRNAs)
Fibroblast growth factor
receptor-1 (FGFR1) (target
of both miRNAs)
Chamorro-
Jorganes et al.,
2011
miR-22 Fluorescent-labelled transgenic zebrafish Tg(fli1:EGFP)
embryo expressing GFP in ECs
MiR-22 injection in zebrafish embryos resulted in defective vascular development
which was rescued with miR-22 and VE-cadherin co-injection. miR-22 negative
control (NC) injection in zebrafish embryos resulted in normal vessel development
Vascular endothelial
(VE)-cdh
Gu et al., 2017
miR-23-24-
27 cluster
(miR-24)
HUVEC
Tg(kdrl:eGFP)s843 zebrafish embryos
Male C57BL/6 mice- MI induction by LAD coronary
artery ligation
Decreased HUVEC tube formation, proliferation and migration post-miR
overexpression in-vitro. Increased vascular defects in miR-24–overexpressing
zebrafish compared with controls. Increased capillary and arteriolar density
post-miR-24 inhibition in a MI mouse model
PAK4
GATA2
Fiedler et al., 2011
miR-23-24-
27 cluster
(miR-24-3p)
HUVECs
Male CD1 mice-HLI model induction by left femoral
artery ligation
Decreased EC survival, tube formation and proliferation post-transfection with
pre-miR-24-3p in-vitro. Opposite results post-miR inhibition in-vitro. Increased
capillary density post-miR inhibition in-vivo, but decreased blood perfusion since the
new vessels appeared disorganised and twisted
Notch1
Dll1
Marchetti et al.,
2020
miR-26a HUVECs
flk:eGFP zebrafish embryos
Male C57BL/6 mice- MI induction by LAD coronary
artery ligation
Decreased HUVEC tube formation and migration post-miR overexpression in-vitro.
Overexpression of miR-26a in zebrafish impaired the development of caudal vein
plexus (CVP) axial vein. Reduced infarct size and increased number of CD31+ cells
after miR-26a inhibition in mice post-MI
SMAD Family Member 1
(SMAD1)
Icli et al., 2013
miR-34 Male C57BL/6 mice- MI induction by LAD coronary
artery ligation
Improved cardiac function, capillary density and left ventricle remodelling
post-inhibition of miR-34 in-vivo compared with controls
Unknown Bernardo et al.,
2012
miR-17-92
Cluster
(miR-92a)
Pig-ischaemia/reperfusion induction (percutaneous
transluminal coronary angioplasty balloon was placed
in the LAD artery distal to the first diagonal branch for
49-60 minutes
MiR-92a–deficient mice- MI induction by LAD coronary
artery ligation
C57Bl/6 mice-MI induction by LAD coronary artery
ligation & HLI induction by ligation of the superficial and
deep femoral artery and vein
Increased capillary density and reduced cardiac inflammation and post-mir-92α
inhibition in mouse and pig MI models and in a HLI mouse model compared with
controls
INTGA5 Bonauer et al.,
2009; Hinkel et al.,
2013; Bellera
et al., 2014
miR-100 HUVECs
C57/Bl6J mice- HLI induced by double ligation of the
superficial femoral artery proximal to the deep femoral
artery and distal femoral artery
Increased HUVEC tube formation, proliferation and migration post-miR inhibition
in-vitro. Opposite effects were observed post-miR-overexpression in-vitro. Increased
perfusion and capillary and arterial density post-miR-100 inhibition in-vivo compared
with controls
Unknown Grundmann et al.,
2011
miR-124 HUVEC
Male C57BL/6 mice- thoracic aorta constriction (TAC)
Increased HUVEC tube formation, proliferation and migration post-miR inhibition
in-vitro. Opposite effects were observed post-miR-overexpression in-vitro. Impaired
cardiac function and blood flow in intravenous adeno-associated virus
(AAV)-miR-124-injected mice compared with controls
CD151 Zhao et al., 2018
(Continued)
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TABLE 1 | Continued
miRNA Model Effect Experimentally confirmed
molecular targets
References
miR-
132/212
HUVEC
Mice- HLI induced by double ligation of the superficial
femoral artery proximal to the deep femoral artery and
distal femoral artery
Decreased tube formation and migration of EC in-vitro post-miRNA overexpression.
Opposite effects were observed post-miRNA inhibition. Increased capillary and
arterial density post-miRNA inhibition in-vivo
RAS p21 protein activator 1
(Rasa1) (previously identified
target of miR-132)
SPRED1 (target of both
miRNAs)
Spry1 (target of
both miRNAs)
Lei et al., 2015
miR-135-3p HUVEC Increased HUVEC tube formation, proliferation and migration post-miR inhibition
in-vitro. Opposite effects were observed post-miR-overexpression in-vitro
Huntingtin-interacting
protein 1 (HIP1)
Icli et al., 2019b
miR-142a-
3p
Tg(fli1:EGFP)y1 zebrafish embryos expressing GFP in
ECs
Loss of vascular integrity, haemorrhage and vascular remodelling post-injection of
miR-142a-3p in zebrafish embryos. Normal primary vasculature but defective
intersegmental vessels (Se) and abnormal remodelling in miR-142a-3p knock-out
embryos
Cdh5 (VE-cdh) Lalwani et al.,
2012
miR-
143/145
cluster
(miR-143,
miR-145)
HUVECs Increased HUVEC tube formation and proliferation post-miR inhibition. Opposite
results post-miR-143/-145 overexpression in-vitro
Hexokinase II (HKII)
(miR-143 target)
Integrin β (miR-145 target)
Climent et al.,
2015
miR-183
cluster
(miR-96,
miR-182,
miR-183)
Mouse cardiac endothelial cells (MCECs)
HCMECs
C57BL/6N mice -MI induction by LAD coronary artery
ligation
miR-96/miR-183 knock-out mice -MI induction by LAD
coronary artery ligation
Overexpression of miR-96 and/or miR183 reduced tube formation and proliferation,
but no migration of neonatal MCECs in-vitro. Inhibition of miR-183 cluster improved
tube formation, proliferation and migration of adult MCECs in-vitro. Inhibition of
miR-96 and miR-183 increased tube formation and proliferation of adult MCEC
in-vitro, whereas miR-182 inhibition did not affect these measures. Similarly,
overexpression of miR-96 and miR-183 in HCMECs reduced tube formation and
proliferation, whereas dual inhibition of these miRs increased both parameters.
Injection of miR-96 and miR-183 mimics in neonatal mice post-MI decreased
vascularisation around the fibrotic tissue and increased the retention of scar tissue. MI
induction in miR-96/miR-183 knockout mice resulted in increased capillary and
arteriole densities, nut cardiac function and fibrosis did not change significantly
compared to the WT controls.
Anillin (ANLN) Castellan et al.,
2020
miR-185 HMVECs Decreased HMVEC tube formation, proliferation and migration post-miR
overexpression. Opposite results post-miR-inhibition in-vitro
Stromal interaction molecule
1 (STIM1)
Hou et al., 2016
miR-199a-
5p
Bovine aortic endothelial cell (BAEC) Increased EC tube formation post-miRNA inhibition in-vitro VEGFA (target in HEK293
cells)
Calcineurin (target in
HEK293 cells)
SOD1 (target in
HEK293 cells
Joris et al., 2018
miR-214 EPCs
HUVECs
Mice-HLI induction by right femoral artery and the
distal portion of saphenous artery ligation
C57BL/6 mice- TAC restriction
Increased EPC tube formation post-miR inhibition. Increased HUVEC tube formation,
proliferation and migration post-miR inhibition. Opposite results post-miR-214
overexpression in-vitro. Increased blood flow by transplantation of EPC, in which
miR-214 was inhibited, to the ischaemic limb tissue. Improved cardiac function and
increased number of capillaries post-AAV9-anti-miR-214 injection compared with
controls
X-box binding protein 1
(XBP1)
Duan et al., 2015;
Jin et al., 2015
(Continued)
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TABLE 1 | Continued
miRNA Model Effect Experimentally confirmed
molecular targets
References
miR-217 HUVECs
HAECs
HCAECs
Decreased EC tube formation and migration post-miR overexpression in-vitro.
Opposite results post-miR-inhibition in-vitro
Silent Information Regulator
1 (SirT1) (target of miR-217)
Menghini et al.,
2009
miR-
221/222
HUVECs Decreased HUVEC tube formation and migration post-miR overexpression in-vitro Signal transducer and
activator of transcription 5A
(STAT5A) (miR-222 target)
Poliseno et al.,
2006; Dentelli
et al., 2010
miR-342-5p HUVEC
mouse aortas from endothelial-specific
Notch-activating mice
Decreased HUVEC tube formation and migration post-miR overexpression in-vitro.
Decreased EC sprouting in aortic rings post-miR mimic transfection ex-vitro
Endoglin Yan et al., 2016
miR-483-5p HUVECs Decreased HUVEC tube formation and migration post-miR overexpression. Opposite
results post-miR-inhibition in-vitro
Serum response factor
(SRF)
Qiao et al., 2011
miR-615-5p HUVEC
C57BL/6 mice-HLI induced by femoral artery ligation
Increased HUVEC tube formation, proliferation and migration post-miR inhibition
in-vitro. Opposite effects were observed post-miR-overexpression in-vitro. Improved
blood flow recovery and capillary density post-miRNA inhibition in-vivo
IGF-2
Ras-associating domain
family member 2 (RASSF2)
Icli et al., 2019a
miR-665 HUVECs
Human cardiac microvascular endothelial cells
(HCMVECs)
Male C57BL/6 mice- TAC restriction
Decreased HUVEC tube formation, proliferation and migration post-miR
overexpression in-vitro. Opposite results post-miR-inhibition in-vitro. Increased
coronary microvessel density and improved heart function post-miR-665 inhibition
in vivo
Ago2 Fan et al., 2018
miR-939 HUVECs Decreased HUVEC tube formation, proliferation and adhesion, but increased
migration post-miR overexpression in-vitro. Opposite results post-miR-inhibition
in-vitro
γ-catenin Hou et al., 2017
miRNAs WITH OPPOSITE IN-VITRO AND IN-VIVO FUNCTIONS
miR-146a HUVEC
Balb/c mice-femoral artery ligation
Impaired EC tube formation and proliferation post-miRNA inhibition in-vitro. In vivo,
miRNA inhibition post-femoral artery ligation did not affect capillary density but
significantly increased collateral artery diameter (arteriogenesis)
Unknown Heuslein et al.,
2018
miR-155 HUVECs
Aortic rings from miR-155−/− mice
C57/BL6J mice- HLI induction by double ligation of the
superficial femoral artery proximal and distal to the
deep femoral artery
miR-155−/− mice- HLI induction by double ligation of
the superficial femoral artery proximal and distal to the
deep femoral artery
Increased HUVEC tube formation and proliferation post-miRNA inhibition in-vitro.
Decreased EC sprouting in aortic rings from miR-155−/− mice. Decreased blood flow
recovery post-ischaemia in miR-155-deficient mice compared to controls
Angiotensin II receptor type I
(AGTR1)
Pankratz et al.,
2015
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(Biyashev et al., 2012). Veliceasa et al. (2015), also showed that
overexpression of miR-27b in a mouse MI model increased
capillary density and reperfusion, and improved cardiac function
with an approximately 2-fold increase in ejection fraction
over the control 14 days post-MI, and significantly reduced
fibrosis at day 28.
On the other hand, several miRNAs have an inhibitory role
in post-ischaemic neovascularisation. Overexpression of another
component of cluster miR-23-24-27, miR-24, significantly
impaired angiogenesis in zebrafish embryos by targeting p21
activated kinase (PAK4) and global transcription factor binding
protein 2 (GATA2). Inhibition of this miRNA with chemically
engineered cholesterol-conjugated single-strand RNA analogues
(antagomirs) in a MI mice model increased capillary and
arteriolar density, and improved cardiac function 14 days
post-MI (Fiedler et al., 2011). The miRNA 17-92 cluster also
has a prominent role in the regulation of post-ischaemic
neovascularisation. Overexpression of the miR-92a component
of this cluster has been reported to block angiogenesis in-vitro
and in-vivo. Among the verified targets of miR-92a, integrin
alpha 5 (ITGA5) critically influences EC proliferation and
migration (Bonauer et al., 2009; Doebele et al., 2010; Daniel
et al., 2014). Interestingly, antimir-92a (MRG-110) was evaluated
in clinical trials; the results showed increased angiogenesis
and blood perfusion following intradermal injection at the
site of a small skin wound in healthy volunteers, as well as
reduced alpha-smooth muscle actin (α-SMA) expression, which
is correlated with activation of myofibroblasts (Safety Tolerability
Pharmacokinetics, 2018).
EVs IN NEOVASCULARISATION
Over the past few years, EVs have emerged as novel regulators of
therapeutic processes, including cardiac neovascularisation due
to their ability to transfermolecules, such asmiRNAs, in ECs. EVs
are defined as heterogeneous plasma membrane vesicles and are
released in the extracellular space under normal and pathological
conditions (Raposo and Stahl, 2019). According to their size and
biogenesis pathway, they can be classified into three main types:
exosomes, microvesicles and apoptotic bodies.
Exosomes are a class of cell-derived EVs of endosomal
origin that are typically 30–150 nm in diameter and contain
various macromolecules derived from the cell of origin. These
include miRNAs, proteins, lipids and mRNAs (Isola and Chen,
2016). Exosome biogenesis starts from the intraluminal budding
of endosomal compartments. This forms intraluminal vesicles
(ILVs) in the endosomal compartments, which are known
as multivesicular bodies (MVBs). MVBs can either fuse with
lysosomes for subsequent degradation or fuse with the plasma
membrane releasing the ILVs, in the extracellular space as
exosomes. In contrast to exosomes, microvesicles, are typically
100–1,000 nm in size and are formed by the outward blebbing of
the plasma membrane. During the blebbing process, disruption
of the actin cytoskeleton and membrane reorganisation occurs
(Cocucci and Meldolesi, 2015). The modification of membrane
asymmetry results in the redistribution of aminophosholipids to
the outer part of the cell membrane. Interestingly, microvesicle
formation seems to occur in lipid-rich microdomains of the
plasma membrane, such as lipid-rafts or caveolae domains (Del
Conde et al., 2005; Morel et al., 2009). On the other hand,
apoptotic bodies are exclusively formed during the last steps of
apoptosis and range from 800 nm to 5µm (Caruso and Poon,
2018). Investigating the mechanisms of EV release and uptake
by ECs is critical to understand their role in neovascularisation
under pathological conditions, such as MI. Recently, a new
population of non-membranous nanoparticles ∼35 nm in size,
termed “exomeres” was identified (Zhang H. et al., 2018; Zhang
et al., 2019). Zhang H. et al. (2018), recently showed that
exomeres have a distinct protein, lipid, DNA and RNA profile to
exosomes, and demonstrate unique organ distribution patterns,
suggesting different biological functions. In contrast to EVs,
exomere biogenesis remains unclear.
EV Release by ECs
EV release is a complex process that involves cytoskeletal
proteins (actin and microtubules), molecular motors (kinesins
and myosins), as well as molecular switches (small GTPases) and
the fusion machinery (SNAREs and tethering factors) (Raposo
and Stoorvogel, 2013). Ras-related proteins in brain (RAB)
family, including Rab11, Rab27a/27b, and Rab35 coordinate
membrane trafficking events, and have emerged as essential
components of exosomal release in several cell types (Savina
et al., 2002; Hsu et al., 2010; Ostrowski et al., 2010).
Rab7 is another member of RAB family that mediates the
maturation of late endosome and mediates their fusion with
lysosomes (Vanlandingham and Ceresa, 2009). Jaé et al. (2015),
showed that Rab7 and Rab27b regulate the secretion of
endothelial miRNA through EVs. Moreover, Ostrowski et al.
(2010), demonstrated that knocking down the Rab27a/27b
effectors synaptotagmin-like 4 (SYTL4) (also known as Slp4)
and exophilin 5 (EXPH5) also inhibits exosome secretion in
HEK293 cells. Interestingly, Slp4 was also shown to have a
central role in Weibel-Palade body (WPB) exocytosis from
ECs (Bierings et al., 2012).
Although our understanding of the exact mechanism of EV-
release from EC is lacking, several factors have been shown
to trigger the release of EVs from ECs. EC injury is a critical
part of the development of CHD and significantly affects the
levels of EC-derived EVs (Werner et al., 2006). In general, EC-
EVs are present at lower concentrations under physiological
conditions and, upon activation, are released from ECs (Koga
et al., 2005). Elevated levels of plasma EC microparticles have
been reported in several CVD, including CHD (Koga et al.,
2005; Werner et al., 2006; Nozaki et al., 2009). Moreover,
clinical studies in heart failure patients have revealed that
the number of circulating EVs from ECs and EPCs greatly
depends on the severity of heart failure. Berezin et al. (2016),
for instance, showed that heart failure patients with preserved
ejection fraction had an increased number of apoptotic EC-
derived EVs and less activated EC-derived EVs than patients
with heart failure with reduced injection fraction. Interestingly,
EC-derived EVs have been proposed as novel biomarkers of
EC dysfunction and may determine the risk of acute heart
failure (Horstman, 2004).
EVs of endothelial origin have been found to play a versatile
role in neovascularisation since their effect seems to be affected
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by the dose used. Lacroix et al. (2007), for instance, showed
that low amounts of microparticles (2 × 103 particles/well, in a
96-well plate) from TNFa-stimulated HMVECs could increase
tube formation of endothelial progenitor derived cells (EPDCs)
in-vitro. In contrast, high amounts of microparticles (2 × 105
particles/well, in a 96-well plate) had an inhibitory effect. Liang
et al. (2018), showed that hypoxic HUVEC EVs could also inhibit
EC migration and angiogenesis probably due to increased levels
of miR-19b in these EVs (5 x 104 EVs/well, in a 6-well plate were
used). The ability of ECs to stimulate angiogenesis may involve
the transfer of miR-214 (Balkom et al., 2013). Interestingly,
Chen et al. (2018), showed that EPC-derived EVs could increase
angiogenesis but not proliferation in-vitro (7 × 109 EVs, in
a 24-well plate). The intramyocardial delivery of EPC-derived
EVs incorporated into shear-thinning hydrogels in Wistar rats,
could increase angiogenesis, preserve ventricular geometry and
improve haemodynamic function post-MI (9.33 × 109 EVs were
delivered via 5 × 20 µl injections around the border zone of
the infarcted area). Ou et al. (2011), however, demonstrated
that endothelial microparticles from HUVECs in increased
concentrations (higher than 105 microparticles/ml) could inhibit
angiogenesis in mouse heart sections. These data suggest that EC
release EVs with diverse roles in neovascularisation.
EV Uptake by ECs
EVs transfer information to the recipient cells by various
mechanisms, including clathrin-mediated endocytosis,
micropinocytosis, phagocytosis, caveolin-mediated endocytosis,
and lipid raft mediated endocytosis (Mulcahy et al., 2014).
The glycoproteins [e.g., Heparan sulphate proteoglycans
(HSPG) (Christianson et al., 2013)] and proteins [e.g., integrins
(Morelli et al., 2004), tetraspanins (Hemler, 2005)] on the
surfaces of EVs and their target cells are recognised as critical
factors that determine the uptake mechanism. Nazarenko et al.
(2010), showed that treating exosomes with antibodies against
tetraspanin-8, integrin CD49d, and vascular cell adhesion
molecule-1 (VCAM-1, CD106) significantly reduced exosome
uptake by RAECs. However, the precise mechanisms of
EV uptake by ECs is still unknown. Some EVs can deliver their
content to ECs through clathrin-mediated endocytosis. Dynamin
is a GTPase essential for membrane fusion during this process.
Blocking dynamin activity is a common strategy to study this
mechanism (Singh et al., 2017). Chiba et al. (2018), showed
that pancreatic cancer cell exosomes may be transferred to ECs
through dynamin-dependent clathrin-mediated endocytosis,
resulting in increased angiogenesis in-vitro. This was verified
by blocking dynamin activity with a small inhibitor, called
dynasore. Moreover, Svensson et al. (2013), reported that
internalisation of exosomes derived from glioblastoma cells
by ECs is significantly decreased post-methyl-β-cyclodextrin
(MβCD) treatment. MβCD is a water-soluble oligosaccharide
able to remove cholesterol from cell membranes, suggesting that
lipid-raft endocytosis is a critical mechanism of EV uptake.
The most commonly used method for detecting EV uptake by
ECs in-vitro and in-vivo is by using fluorescent lipid membrane
dyes that stain EV membranes, such as PKH67 (Balkom et al.,
2013), PKH26 (Lopatina et al., 2014; Lombardo et al., 2016; Zou
et al., 2016; Mao et al., 2019) and DiI (Liang et al., 2016). Lopatina
et al. (2014), for instance, showed that PKH26-stained MSC-EVs
could be internalised into HMVECs and promote angiogenesis
in-vitro and in-vivo. Moreover, Liang et al., demonstrated that
the uptake of DiI-labelled MSC-exosomes by HUVECs increased
tube formation in-vitro. To assess the role of MSC exosomes
in EC angiogenesis in-vivo, the authors performed Matrigel
plug assays in mice subcutaneously injecting HUVECs mixed
with MSC-exosomes and HUVEC alone, and consistently with
their in-vitro data, they showed that MSC-exosomes resulted in
increased angiogenesis in-vivo. One potential issue with lipid-
bound dyes is the leaching of the fluorescent molecules onto the
cellular membranes, which can lead to a pattern of internalisation
due tomembrane recycling rather than EV uptake. To distinguish
between surface-bound and internalised fluorescent EVs, the
surface of the cell can be treated with trypsin (Franzen et al.,
2014). A further limitation of these dyes is that the presence of
the fluorescent molecules may affect the physical properties and
thus, the normal behaviour of EVs. Membrane permeable dyes,
such as carboxyfluorescein succinimidyl ester (CFSE) and 5(6)-
carboxyfluorescein diacetate (CFDA), that are confined to the
cytosol and fluoresce as a consequence of esterification, as well
as Calcein AM are also used to study EV uptake by ECs (Teng
et al., 2015; Li et al., 2018; Merckx et al., 2020). Radionuclides and
magnetic particles have also been exploited to label EVs. Lee et al.
(2020), for instance, recently showed that nanovesicles derived
from iron oxide NP-incorporated MSCs could be effectively
targeted to the myocardium of rats promoting cardiac function
and angiogenesis. Finally, by fusing Gluc to a protein enriched
in the membrane of exosomes, such as lactadherin, exosomes
can emanate a strong luminescent signal when a Gluc substrate
is present (Zhang K. et al., 2018). EVs can also be labelled with
GFP by expressing a DNA construct coding for EV markers
such as CD63, CD81, and CD9 fused to GFP in parent cells.
This way, EVs can be tracked or purified to study their cargo
(Garcia et al., 2015; Ribeiro-Rodrigues et al., 2017). Nonetheless,
visualising GFP-labelled EV uptake by conventional fluorescent
microscopy techniques is challenging due to the small nature of
EVs. For this reason, the use of advanced technologies, including
electron microscopy and atomic force microscopy are useful in
EV characterisation (Mondal et al., 2019).
Recently, Cre-loxP system was also introduced as a very
promising strategy to study EV uptake by cancer cells (Zomer
et al., 2016). Adapting this system, de la Cuesta et al. (2019),
visualised direct transfer of human pulmonary artery smooth
muscle cells (HPASMCs) EVs to human pulmonary arterial
endothelial cells (HPAECs). In particular, donor HPASMCs
were transduced with a Cre recombinase lentiviral vector and
HPAECs with a reporter lentiviral vector, that carried DsRed
and eGFP separated by a loxP site. Cells were co-cultured in
Boyden chambers, being physically separated by a membrane to
prevent direct cell-cell contact. Zomer et al. (2015), previously
showed that in this system, only Cre mRNA and not Cre
protein is transferred into EVs. By performing qRT-PCR de la
Cuesta et al. (2019) confirmed efficient loading of Cre mRNA
into HPASMC-EVs. Using this system, the authors showed that
HPASMC-EV-mediated Cre recombination resulted in a colour
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switch from red to green in reporter+ HPAECs, effectively
evidencing communication via EVs. Therefore, the advantage
of this approach is that EV uptake can be visualised in a more
sensitive manner since it results in the fluorescent labelling of
whole cells instead of small EVs.
Animal Models to Study EV Trafficking
One of the greatest limitations in using purified labelled EVs from
cell culture supernatants into the circulation of animal models
is the difficulty to translate the in-vivo implications of EVs at
a functional level. The variations observed in studies using EVs
from different cell sources, the number of particles injected, the
route of administration as well as the fact that most studies
are implemented in immunodeficient animals, are all important
variables in the design and analysis of experimental data. For
this reason, genetically engineeredmousemodels (GEMM) could
provide a promising approach to outreach current limitations
allowing tracing of EVs in living organisms. As previously
mentioned, a new strategy that allows the study of EV transfer
in-vitro and in-vivo using the Cre/loxP system was reported
(Zomer et al., 2016). This approach involves the fluorescent
labelling of Cre-reporter cells that take up the EVs released
from cells which express Cre recombinase. In this method,
prior to cell injection into mice ubiquitously expressing the
Cre-LoxP reporter tdTomato (tdTomato B6 mice), cells were
transfected with a plasmid carrying Cre recombinase and cyan
fluorescence protein (CFP). In this way, donor cells expressing
Cre recombinase were CFP positive (blue), and EVs derived
from these cells carried Cre recombinase mRNA. Upon injection,
EVs were taken up by recipient reporter cells that translated
Cre mRNA into protein. This resulted in the recombination of
the reporter gene and activation of GFP expression leading to a
colour switch from red to green fluorescence exclusively in cells
that had taken up functional EVs in-vivo Zomer et al. (2015),
developed this system to study EV communication between
tumour cells. EV-miRNA profiling revealed that malignant
tumour cells contain mRNAs involved in tumour migration
and metastasis. More importantly, intravital imaging, showed
that EVs released by malignant cells can be internalised by less
malignant cells within the same or distal tumours and that the less
malignant tumour cells display enhanced migratory behaviour
and metastatic capacity. The exact mechanism of how the Cre
mRNA is transferred into exosomes remains unclear, but it is
probably a simple reflection of increased cellular expression and
sufficient EV loading. Interestingly, the authors verified that the
colour switch was due to CremRNA containing EVs, and not by
other mechanisms, such as free CremRNA or protein.
Other strategies involve the controlled expression of Cre
recombinase under specific promotors. For example, CremRNA
can be expressed selectively in haematopoietic cells under the
vav1 promoter and sorted into EVs released into the bloodstream.
Upon entering a target cell, this mRNA is translated to a
functional protein, leading to excision of the stop-loxP site
and induction of marker gene expression in transgenic mice.
Based on this, Kur et al. (2020), proved that neuronal activity
triggers the uptake of haematopoietic extracellular vesicles in
vivo. In particular, they showed that after the induction of
peripheral inflammation by intraperitoneal (IP) injection of
lipopolysaccharide (LPS), there were frequent recombination
events in the hippocampus, substantia nigra, and other regions
of the brain as observed by yellow fluorescent protein (EYFP)
expression. EYFP expression was mediated by Cre recombinase
activity, indicating that haematopoietic cell EVs were transferred
and internalised in these regions of the brain. Although most
studies utilising GEMM to assess EV uptake are focused
on cancer or neuroscience research, the adaptation of these
animal models could greatly increase our knowledge in EV
communication in cardiovascular disease, including MI. The
use of the Cre-loxP system has significantly increased our
understanding of EV communication. However, the fact that
Cre mRNA can be loaded in and transferred through EVs may
doubt the validity of approaches using the Cre-loxP system in a
tissue-specific manner, since upon activation of Cre expression
in specific cells, Cre mRNA or protein can be transferred
to other cell types through EVs, leading to unfavourable
recombination events.
Recently, McCann et al. (2020), generated a reporter mouse
bearing a CD63-emGFPloxP/stop/loxP knock-in cassette that
enables the labelling of cell type-specific EVs in-vivo, without
prior in vitro manipulation. Upon crossing with a lineage-
specific Cre recombinase driver mice, this system enables the
specific labelling of circulating CD63+ vesicles from the cell
type of interest. By crossing the mice bearing the CD63-
emGFPloxP/stop/loxP knock-in cassette with Cdh5-CreERT2 mice,
the authors generated CD63emGFP+ vasculature and showed
that following tamoxifen administration to pregnant females the
developing vasculature of the embryos was marked with emerald
GFP (emGFP). Most importantly, whole plasma-purified EVs
contained a subpopulation of emGFP+ vesicles that co-expressed
EV markers, including CD9 and CD81, and EC markers,
like CD105.
Altogether, the recent development of genetically modified
mouse models to study EV trafficking in-vivo holds great promise
as valuable tools for unravelling the in-vivo relevance of EVs in
physiological and pathophysiological processes such as cardiac
neovascularisation after cardiac ischemia.
EVs in Therapeutic Neovascularisation
EVs possess inherent tissue repair properties that make them
ideal candidates for regenerative medicine therapeutics. Several
studies have demonstrated the ability of EVs to promote
neovascularisation post-ischaemia. Gallet et al. (2017), showed
that intramyocardial delivery of cardiosphere-derived cell (CDC)
exosomes in a pig MI model increased vessel density and
cardiomyocyte hypertrophy, while preserving left ventricular
(LV) and left ventricular ejection fraction (LVEF) volumes
and reducing scar size. Moreover, Potz et al. (2018), showed
that intramyocardial injection of human mesenchymal cell-
derived EVs in a swine MI model could increase blood flow,
capillary and arteriolar density 5 weeks post-left circumflex
artery ligation. Chen et al. (2020), aimed to investigate the
role of exosomes derived from remote ischemic conditioning
(RIC) in cardiac remodelling and function. Exosomes were
isolated from the plasma of rats subjected to HLI and injected
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to the caudal vein of rats once every 3 days post-MI. The
authors showed that RIC and RIC exosomes significantly
improved cardiac function and blood vessel formation, and
decreased collagen deposition 28 days post-MI. Wu et al. (2020),
demonstrated that the intramyocardial injection of EVs from
ESC-derived cardiovascular progenitor cells (CVPCs) cultured
under normoxia or hypoxia could significantly improve cardiac
function, vascularisation and cardiomyocyte survival, and reduce
fibrosis at 28 days in a mouse MI model. More importantly, EVs
secreted from ESC-CVPC cultured under hypoxia had a better
benefit in improving cardiac function post-MI.
EVs possess several advantages over cell-based therapeutics
and conventional delivery systems. A major advantage is that
EVs may be less immunogenic than their parental cells, probably
due to the presence of less membrane-bound proteins like
MHC complexes on their surface (Ong and Wu, 2015). The
number of MHC molecules on EV surface highly depends on
the cell of origin and the EV subtype (Wahlund et al., 2017).
Recently, Kompa et al. (2020), used a subcutaneously implanted
TheraCyte device for sustained delivery of the secretome of
human cardiac stem cells (hCSCs) in a rat MI model. Cells can
be enclosed in the TheraCyte device, being protected by the host’s
immune system while allowing the therapeutic secreted products
to freely diffuse from within the device. The authors showed that
hCSC secretome could preserve LV ejection fraction and cardiac
function, reduce fibrotic scar tissue, interstitial fibrosis and
cardiomyocyte hypertrophy, while increasing vascular density.
To visualise the EV transfer from hCSC to the myocardium,
they used CSCs expressing plasma membrane reporters and
confirmed that EVs from W8B2+ CSCs could be transferred to
the heart and other organs 4 weeks post-implantation. A further
advantage of EVs is that they can be easily stored, retaining their
function over prolonged periods, overcoming many limitations
of the use of viable cells in regenerative medicine. Moreover, EVs
are naturally occurring lipid nanoformulations that, compared to
other synthetic drug delivery systems, may be promising carriers
of therapeutic molecules, exhibiting less toxicity and increased
stability under both physiological and pathological conditions.
EVs might also be combined with other strategies to optimise
therapeutic agent delivery. Liang et al. (2017), showed that
exosomes could naturally envelope AAV-vectors (AAVExo) and
protected from plasma neutralising antibodies, AAVExo could
transduce cardiomyocytes with higher efficiency than free AAVs
in a mouse MI model. For these reasons, EVs have emerged
as ideal carriers for the delivery of therapeutic molecules, such
as miRNAs, to ECs for the promotion of neovascularisation
post ischaemia.
EV-bound miRNAs in Neovascularisation
EVs exert their action through the transfer of molecules, such
as small RNAs and proteins, able to control molecular pathways
in the recipient cells once transferred. For this reason, they
have gained immense interest as therapeutic vehicles. Among
their multidimensional role, several studies have demonstrated
the ability of EVs to stimulate vascular growth and maturation
by delivering pro-angiogenic miRNA molecules to ECs. Table 2
contains a list of EV-bound miRNAs as reported in EV-based
neovascularisation studies. However, since our intention was to
identify EV-bound miRNAs with a role in neovascularisation,
this table contains a simple summary of our findings with an
emphasis on the miRNAs, and due to space constraints, not all
EV-producing cell types are reported.
EV-bound miRNA molecules can be internalised in the
cytoplasm of recipient cells and activate molecular pathways
controlling cell behaviour (Figure 2). Barile et al. (2014), for
instance, showed that EVs from human cardiac progenitor cells
(hCPCs) were enriched in the angiogenic and cardioprotective
miR-210, miR-132, and miR-146a-3p. As a result, EVs derived
from these cells could significantly increase cardiac angiogenesis
in a MI rat model. Wang et al. (2017), demonstrated that
MSC-derived EVs were also enriched in miR-210. Treatment
with MSC-EVs significantly increased HUVEC tube formation,
proliferation and migration in-vitro and capillary density
of matrigel plugs implanted in a mouse MI model by
targeting Efna3. Silencing of miR-210 in MSC-EVs significantly
impaired the in-vitro and in-vivo angiogenic effects. Adamiak
et al. (2018), showed that treatment with iPSC-derived EVs,
promoted murine cardiac EC tube formation, migration and
antiapoptotic properties. Injection of iPSCs-EVs in a mouse
MI model significantly increased capillary density & reduced
LV remodelling and hypertrophy compared to the controls. EV
microRNA expression profiling was performed by miRNA array
and revealed that several miRNAs were upregulated in these
EVs, including miR-16, miR-17-92, miR-19b, miR-20a, miR-34,
miR-126-3p, miR-130a-3p, miR-210-3p, miR-294.
Specific conditions, such as hypoxia greatly affect gene
expression and favour the production of miRNAs with
angiogenic properties. As a result, several studies have confirmed
that hypoxia leads to the release of angiogenic EVs. Ribeiro-
Rodriquez et al. for instance, demonstrated that exosomes
secreted by H9c2 myocardial cells and primary cardiomyocytes
cultured under hypoxic conditions significantly increased the
formation of new functional vessels post-MI in rats in
comparison with exosomes cultured under normoxic conditions.
An analysis of the miRNA profile of these exosomes revealed
that the pro-angiogenic miR-222 and miR-143 were significantly
increased in the hypoxic exosomes providing evidence that these
miRNAs may contribute to post-ischemic neovascularisation
(Ribeiro-Rodrigues et al., 2017). Similarly, Zhu et al. (2018),
showed that exosomes derived from hypoxic MSCs augmented
neovascularisation in a MI mouse model. Exosome RNA
profiling revealed 145 genes that were upregulated in the hypoxic
exosomes compared to the normoxic ones, with miR-210 being
one of the most abundant miRNAs. To investigate the role of
miR-210 in hypoxic-EV induced angiogenesis, the authors used
a miR-210 inhibitor to block the activity of miR-210 in MSCs and
revealed that exosomes derived from these cells failed to induce
angiogenesis in-vitro. Moreover, overexpression of miR-210 in
ECs resulted in improved tube formation similar to that achieved
by hypoxic exosomes. Gray et al. (2015), reported that treatment
with hypoxic EVs derived from CPCs significantly increased rat
cardiac EC tube formation compared to treatment with normoxic
EVs. Injection of hypoxic EVs in a mouse MI model significantly
improved cardiac function and reduced fibrosis. EV microRNA
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TABLE 2 | EV-bound miRNAs in the regulation of cardiovascular neovascularisation.
EV miRNA Model Effect EV source EV isolation method References
miR-15b
miR-17
miR-20a
miR-103
miR-199a
miR-210
miR-292
Rat cardiac endothelial cells
Male Sprague-Dawley rats- MI
induction by LAD coronary
artery ligation
Increased EC tube formation post-hypoxic EV treatment in-vitro. Improved cardiac
function and reduced fibrosis post-intramyocardial EV injection at 3 border zones. EV
microRNA expression profiling by qPCR miRNA array revealed several upregulated
miRNAs under hypoxic conditions
Normoxic/ hypoxic CPCs Differential centrifugation
ultracentrifugation
Gray et al., 2015
miR-16
miR-17-92
miR-19b
miR-20a
miR-34
miR-126-3p
miR-130a-3p
miR-210-3p
miR-294
Murine cardiac ECs. C57BL6/J
mice- MI induction by 30-min
coronary occlusion followed by
reperfusion
Increased EC tube formation, migration and antiapoptotic properties post-EV
treatment in-vitro. Increased capillary density & reduced LV remodelling and
hypertrophy post-intramyocardial injection of EVs at 5 sites at the border between
infarcted and non-infarcted myocardium 48h post-reperfusion. EV microRNA
expression profiling was performed by miRNA array and revealed several upregulated
miRNAs.
iPSCs Differential centrifugation
ultracentrifugation
Adamiak et al.,
2018
miR-17
miR-19a
miR-19b
miR-20a
miR-30c
miR-126
HUVECs Increased EC tube formation, proliferation and migration post-exosome treatment
in-vitro. EV microRNA expression profiling was performed by qPCR miRNA array and
revealed increased levels of several miRNAs in these exosomes
Glucose starved H9C2
cardiomyocytes
Differential centrifugation
ultracentrifugation
Garcia et al., 2015
miR-20b
miR-27b
miR-29b
miR-42a
miR-100
miR-125b
miR-143
miR-195
miR-291b
miR-497
CMVECs
Aortic rings from Male
Sprague-Dawley rats
Male Sprague-Dawley rats-
HLI induction by femoral
artery ligation
Increased EC tube formation, proliferation and migration post-exosome treatment
in-vitro. Increased EC sprouting post-exosome treatment ex-vivo. Increased capillary
density and blood perfusion post-induced vascular progenitor cell (iVPC) exosome
injection as compared with rat aortic endothelial cell (RAEC) exosomes and controls.
EV microRNA expression profiling was performed by qPCR miRNA array and
revealed increased levels of several miRNAs in these exosomes
iVPCs
RAECs
Ultracentrifugation
Ultrafiltration
Size-
exclusion chromatography
Johnson et al.,
2019
miR-21-5p HUVECs
Female CD-1 mice- MI
induction by LAD coronary
artery ligation
Improved EC tube formation in-vitro post-treatment with EVs from patients with
normal angiography results (NEXO) compared to patients with heart failure (FEXO).
Increased capillary density, infarcted wall thickness and decreased infarct size
post-NEXO EV treatment compared to FEXO EVs and PBS controls
post-intramyocardial injection. Decreased miR-21-5p expression in FEXO compared
to NEXO group identified by EV microRNA expression profiling by qPCR miRNA array.
Silencing of miR-21-5p in NEXO group decreased tube-formation in-vitro, while
upregulation of miR-21-5p in FEXO group promoted EC tube formation.
Explant-derived cardiac
stromal cells from FEXO
or NEXO patients
Ultracentrifugation Qiao et al., 2019
(Continued)
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TABLE 2 | Continued
EV miRNA Model Effect EV source EV isolation method References
miR-21
miR-27a
miR-29a
miR-126
miR-130α
miR-191
miR-210
miR-296-3p
HMVECs
Human macrovascular
endothelial cells (HMAVECs)
SCID mice
Increased EC tube formation and proliferation post-treatment with EVs from obese
individuals with type 2 diabetes (OD) compared with EVs from healthy individuals (H),
patients with type 2 diabetes (D), obese individuals without T2DM (O), and patients
with ischaemic disease (IC). EVs from patients of the above groups were divided as
“effective” and “ineffective” depending on their effect on angiogenesis in vitro. Matrigel
plug in vivo assays using EVs defined as “effective” in the in vitro assays, showed that
these EVs resulted in an increased number of vessels in mice Matrigel plugs. EV
microRNA expression profiling of “effective” and “ineffective” EVs of healthy individuals
was performed by qPCR miRNA array and identified several angiogenic miRNAs
Human serum from H, D,
OD, D, O, IC individuals
Ultracentrifugation Cavallari et al.,
2020
miR-31 HUVECs
Aortic rings from male
C57BL/6J mice
Increased EC tube formation and migration post-EV treatment in-vitro. Increased EC
sprouting post-EV treatment ex vivo. EV microRNA expression profiling was
performed by qPCR miRNA array and revealed increased levels of miR-31. EVs from
cells transfected with anti-miR-31 decreased EC tube formation and migration
in-vitro, whereas pre-miRNA transfection increased tube formation and migration.
Adipose-Derived Stem
Cells (ADSCs)
Differential centrifugation
Ultracentrifugation
Kang et al., 2016
miR-92a-3p HCAEC EV microRNA expression profiling was performed by qPCR miRNA array and
revealed increased miR-92a-3p levels in oxidised low-density lipoprotein (oxLDL) and
interleukin-6 (IL-6) stimulated HCAEC. Knock-down of this miRNA in HCAEC EVs
decreased their ability to cause HCAEC migration, proliferation, and tube formation
in-vitro.
oxLDL and IL-6
stimulated HCAEC
Differential centrifugation
Ultracentrifugation
Liu et al., 2019
miR-125a-5p HUVEC Increased EC tube formation post-EV treatment in-vitro. EV microRNA expression
profiling was performed by qPCR miRNA array. Overexpression of miR-125a in
HUVECs, increased tube formation in-vitro. Matrigel plug in vivo assay results showed
that the number of vascular structures was significantly higher in mice
subcutaneously injected with HUVECs mixed with EVs than HUVECs alone
MSCs Differential centrifugation
Ultrafiltration
Ultracentrifugation
Liang et al., 2016
miR-126-3p HUVECs
Immunocompromised BalbC
mice- HLI induction by femoral
artery ligation
Increased EC tube formation post-EV treatment in-vitro. EV microRNA expression
profiling was performed by qPCR miRNA array. EVs from cells transfected with
anti-miR-126-3p decreased HUVEC tube formation in-vitro. Improved blood flow and
capillary density post-intramuscular injections of EVs at 4 different sites of the
ischaemic limb.
CD34+ SCs Ultracentrifugation
Density
gradient centrifugation
Mathiyalagan
et al., 2017
miR-126
miR-296
SCID mice- HLI induction by
left femoral artery and the distal
portion of saphenous artery
ligation
Increased capillary density and blood perfusion post-MV injection. Presence of
miR-296/-126 in the EVs was confirmed by qPCR
EPCs Ultracentrifugation Ranghino et al.,
2012
miR-132
miR-146a-3p
miR-181
miR-210
HUVECs
Male Wistar rats- MI induction
by LAD coronary artery ligation
Increased EC tube formation ability post-EV treatment in-vitro. EV microRNA
expression profiling was performed by qPCR miRNA array. HUVECs transfected with
a miR-132 mimic had increased tube formation. Opposite results were observed
post-transfection with si-miR-132. In-vivo experiments revealed increased blood
vessel density post-intramyocardial injection of CPC EV at 3 border zones.
hCPCs ExoQuickTM precipitation
solution (System
Biosciences; SBI)
Ultracentrifugation
column precipitation
using Exo-spinTM kits
(Cell Guidance Systems,
Cambridge, UK)
Barile et al., 2014
(Continued)
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TABLE 2 | Continued
EV miRNA Model Effect EV source EV isolation method References
miR-143
miR-222
MCECs
HUVECs
Rat aortic rings
Fertilised chicken eggs
Female C57BL/6 mice- MI
induction by LAD coronary
artery ligation
EVs from cells in ischaemic solutions increased EC tube formation, proliferation and
protection against oxidative-induced lesion in-vitro and increased EC sprouting
ex-vivo. Intramyocardial injection of hypoxic EVs increased capillary density, the
number of CD31+ cells in the infarcted region and blood perfusion. EV microRNA
expression profiling by qPCR miRNA array revealed increased miR-222/-143
expression in hypoxic EVs
H9c2 myocardial cells &
primary rat
cardiomyocytes from
Wistar rat foetus cultured
in appropriate media or
ischaemia-mimetic
solutions
Differential centrifugation
Density
gradient centrifugation
Ribeiro-Rodrigues
et al., 2017
miR-210 HUVEC
Male C57BL/6 mice- MI
induction by LAD coronary
artery ligation
Increased EC tube formation & decreased apoptosis post-hypoxic EV treatment
in-vitro. EV microRNA expression profiling by qPCR miRNA array revealed increased
miR-210 expression in hypoxic EVs. Transfection of HUVECs with miR-210 mimic
yielded similar results to hypoxic EV treatment. Increased capillary and arteriole
density and CM survival post-intramyocardial injection of hypoxic EVs at five sites
around the border zone of infarcted hearts.
Normoxic/ hypoxic MSCs Differential centrifugation
Ultracentrifugation
Zhu et al., 2018
miR-214 HMVECs Increased EC tube formation and migration post-EV treatment in-vitro. EV microRNA
expression profiling was performed by qPCR miRNA array and showed increased
miR-214 expression. EVs from cells transfected with anti-miR-214 decreased EC
tube formation and migration in-vitro, whereas pre-miRNA transfection did not affect
tube formation and migration.
HMVECs Differential centrifugation
Density
gradient centrifugation
Balkom et al.,
2013
miR-423-5p HUVECs Increased EC tube formation, proliferation and migration post-exosome treatment
in-vitro. EV microRNA expression profiling by small RNA sequencing and qPCR
miRNA array revealed increased levels of miR-423-5p in these exosomes.
Overexpression of miR-423-5p in HUVECs increased their tube formation ability,
proliferation and migration.
hADSCs Differential centrifugation
Ultracentrifugation
Xu et al., 2019
miR-939-5p MCECs
HUVECs
C57BL/6 mice- MI by LAD
coronary artery ligation & HLI
by left femoral artery ligation
Increased EC tube formation, proliferation and migration post-ischaemic exosome
treatment in-vitro. Increased capillary density and reduced scar size post-ischaemic
exosome injection. EV microRNA expression profiling by qPCR miRNA array revealed
decreased miR-939-5p expression in ischaemic exosomes. HUVEC transfection with
miR-939-5p mimic decreased EC tube formation and migration in-vitro, whereas
transfection with miRNA inhibitor increased tube formation and migration.
Coronary blood from
patients with myocardial
ischaemia and control
group
Differential centrifugation
Ultracentrifugation Li et al., 2018
miR-1246 HUVECs Incubation of HUVECs with DLD-1 cancer cell derived EVs significantly increased tube
formation and migration. Mir-1246 was enriched in DLD-1-EVs. Overexpression of
miR-1246 in HUVECs significantly increased their tube formation ability and migration.
DLD-1 cancer cells Ultracentrifugation Yamada et al.,
2014
miR-4306 HCAECs Decreased EC tube formation, migration and proliferation post-treatment with EVs
isolated from the PCI group compared with those from the control group. Human
monocyte-derived macrophage (HMDM) treatment with ox-LDL significantly
increased their miR-4306 levels. Transfection of HCAECs with miR-4306 mimic
significantly inhibited their tube formation ability and slightly suppressed HCAEC
proliferation and migration.
HMDM from patients
who had PCI performed
within 12 hours (PCI
group) and patients with
chest pain syndrome with
normal coronary artery
findings post coronary
angiography
Differential centrifugation
Ultracentrifugation
Yang et al., 2019
let-7b-5p HUVECs
CD1 male mice-HLI induction
by left femoral artery ligation
Increased EC tube formation, proliferation and reduced EC apoptosis post-exosome
treatment in-vitro. EV microRNA expression profiling was performed by qPCR miRNA
array and revealed increased levels of let-7b-5p. Exosomes restored the angiogenic
capacity of DICER knock-out-ECs, but the reduction of exosomal let-7b-5p in
exosomes failed to induce tube formation in recipient DICER-KD ECs in-vitro.
Increased capillary density and blood flow recovery and reduced necrosis
post-exosome injection in-vivo.
Human pericardial fluid
(PF) exosomes
ExoQuick kit (System
Biosciences)
Beltrami et al.,
2017
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FIGURE 2 | Representative examples of EV miRNAs that control EC behaviour. EVs from different cells carry angiogenic miRNAs. Once transferred in ECs, miRNAs
control molecular pathways by inhibiting their mRNA-targets.
expression profiling revealed several upregulated miRNAs under
hypoxic conditions, including miR-15b, miR-17, miR-20a, miR-
103, miR-199a, miR-210, miR-292.
Qiao et al. (2019), compared the effect of exosomes isolated
from explant-derived cardiac stromal cells from patients with
normal angiography results (NEXO) to exosomes from patients
with heart failure (FEXO). They showed that intramyocardial
injection of exosomes from the NEXO group in a mouse MI
model significantly increased capillary density and decreased the
infarct size, while injection of exosomes from the FEXO group
exacerbated cardiac function and left ventricular remodelling.
Exosomes from the FEXO group exhibited reduced ability
to promote HUVEC tube formation in-vitro. EV microRNA
expression profiling revealed decreased miR-21-5p expression
in the FEXO compared to the NEXO group exosomes. As a
result, silencing ofmiR-21-5p inNEXO group decreasedHUVEC
tube-formation, while upregulation of miR-21-5p in FEXO group
restored HUVEC tube formation. Li et al. (2018) showed that EC
treatment with exosomes from coronary blood of patients with
myocardial ischaemia significantly increased EC tube formation,
proliferation and migration in-vitro. Intramyocardial injection
of exosomes in a mouse MI model significantly increased
capillary density and reduced scar size. EVmicroRNA expression
revealed decreased miR-939-5p expression in exosomes from
coronary blood of patients with myocardial ischaemia compared
to exosomes from healthy controls. Transfection of ECs with
miR-939-5p mimic decreased EC tube formation and migration
in-vitro, whereas transfection with miRNA inhibitor increased
tube formation and migration.
Beltrami et al. (2017), showed that human pericardial
fluid exosomes increased EC tube formation, proliferation
and reduced EC apoptosis. EV microRNA expression profiling
revealed that let-7b-5p was increased in these exosomes.
Moreover, human pericardial fluid exosomes restored the
angiogenic capacity of DICER knock-out-ECs in-vitro, but the
reduction of exosomal let-7b-5p in exosomes failed to induce
tube formation in the recipient DICER-KD ECs. Exosome
injection in a mouse HLI model significantly increased capillary
density and blood flow recovery and reduced necrosis. EVs from
CD34+ stem cells also appear to be regulators of angiogenesis.
In particular, Mathiyalagan et al. (2017), demonstrated that
CD34+ cell-derived exosomes are enriched in pro-angiogenic
miRNAs, such as miR-126-3p. As a result, injection of these
exosomes in an HLI mouse model increased miR-126-3p levels
without affecting the endogenous synthesis of this miRNA,
implying a direct transfer of exosomal miR-126-3p to the
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ischaemic limb. Moreover, it was suggested that miR-126-3p
enhanced angiogenesis by suppressing its known target, SPRED1.
Ranghino et al. (2012), reported that the angiogenic miRNAs
miR-126 and miR-296 were upregulated in EPC-derived EVs.
Injection of EPC-derived EVs in a mouse HLI model significantly
increased capillary density and blood perfusion to the ischaemic
muscle. Recently, Johnson et al. (2019), showed that exosomes
from induced vascular progenitor cell (iVPC) could significantly
increase EC tube formation, proliferation and migration in-vitro
and EC sprouting of mouse aortic rings. Exosome injection
in a rat HLI model significantly increased capillary density
and blood perfusion compared with rat aortic endothelial cell
(RAEC) exosomes and controls. EV microRNA expression
profiling revealed increased levels of several miRNAs in these
exosomes, including miR-20b, miR−27b, miR-29b, miR-42a,
miR-100, miR−125b, miR-143, miR-195, miR-291b, miR-497.
Taken together, several studies have reported a role of EV-bound
miRNAs in post-ischaemic neovascularisation. Nonetheless, a
better understanding of their mechanism of action in the
recipient cells is essential before clinical application.
CHALLENGES AND FUTURE
PERSPECTIVES
The delivery of EVs, carrying therapeutic miRNA molecules, to
the heart remains promising for the regulation of therapeutic
neovascularisation post-MI, but there are several challenges to
the field. Our knowledge of endogenous cell communication
via EVs, for instance, both under physiological and pathological
conditions is limited. Therefore, in-vivo visualisation of EV
spatial and temporal release from the vascular wall, as well
as of EV uptake by vascular ECs is of utmost importance
for a better understanding of the biological function of
EVs. To develop EV-based therapeutics, a more in-depth
evaluation of EV pharmacokinetics in-vivo is also crucial. A
critical factor that affects EV pharmacokinetics is the route
of administration. Gallet et al. (2017), showed that CDC-
derived exosomes resulted in improved vessel density and cardiac
function post intramyocardial injection, but were ineffective after
intracoronary injection. Therefore, preclinical models that allow
for the study of endogenous EVs, as well as the biodistribution of
exogenously administrated EVs, must be developed for a better
understanding of their role in cardiac neovascularisation.
Moreover, clinical trials with EV products will only be possible
with the improvement of isolation and purification techniques.
The development of highly reproducible methods of isolating
GMP-quality EVs, however, remains a great challenge in the
field. Due to the lack of standardised cell culture and isolation
methods, numerous studies, use relatively impure populations
of EVs, which may affect angiogenesis assays, leading to wrong
assumptions for their functionality. Lipoproteins are the most
common contaminants from serum-containing medium (Yuana
et al., 2014; Sódar et al., 2016). In this reason, the choice
between culture medium containing EV-depleted serum and
culture medium without serum needs to be considered. Serum
starvation, however, has been reported to cause significant stress
to the cultured cells, which subsequently leads to altered EV
secretion (Witwer et al., 2013). Although this issue can be avoided
by using EV-depleted serum, there are still several limitations
associated with serum EV depletion strategies. Rigorous EV
depletion of FBS using long ultracentrifugation protocols, for
instance, is time-consuming and cannot remove small serum
RNAs which can be mis-annotated as human RNAs (Wei et al.,
2016). More recently introduced ultrafiltration-based strategies
can overcome these limitations and result in solutions of
extremely low EV and small RNA content (Kornilov et al.,
2018). Another major dilemma in the EV field is the lack
of a consensus methodology for the isolation of pure and
intact EVs. Differential centrifugation is the most commonly
used method for EV purification. Further purification from co-
pelleted protein complexes and lipoproteins can be achieved
by a density gradient. Nonetheless, this approach is associated
with increased EV aggregation and usually results in fusion or
disruption of the isolated EVs. Moreover, the optimal parameters
of ultracentrifugation highly dependent on the type of centrifuge
rotor used. Thus, it is essential that alternative approaches be
used. Interestingly, a combination of ultrafiltration with size-
exclusion chromatography has been proposed as a novel EV
isolation approach that yields particles of improved purity and
quality (Nordin et al., 2015).
Using standardised cell culture and EV isolation methods is
extremely important in angiogenesis studies. Depending on the
conditions that EVs have been generated and isolated, as well as
the EV subtype and the dose used, they may exhibit a powerful
proangiogenic or inhibitory effect. Moreover, since cell culture
and EV isolation procedures affect the EV cargo, a more in-
depth characterisation of the way that therapeutic molecules,
such as miRNAs are sorted and released by EVs is essential before
clinical application. EV-driven miRNA transfer post-MI is a
new promising strategy for the promotion of neovascularisation.
Numerous miRNAs including miR-126, miR-92a, miR-210, miR-
27b, and miR-24 have been recognised as key regulators of post-
ischaemic neovascularisation, but only a limited number have
been identified in EVs. KRAS-MEK signalling has been proposed
as an important regulator of miRNA sorting in EVs (McKenzie
et al., 2016). However, the exact molecular mechanisms that drive
miRNA transfer into EVs are not fully understood. Recently,
a CRISPR-Cas-9 based system for single-cell detection of EV-
mediated functional transfer of RNA was put forward (de Jong
et al., 2020). This approach, termed CRISPR Operated Stoplight
System for Functional Intercellular RNA Exchange (CROSS-
FIRE), is based on activation of a fluorescent protein in recipient
reporter cells upon functional delivery of specific sgRNAs,
expressed in EV-donor cells. In general, there is a consensus that
small RNA composition of cells differs from that in EVs, and
emerging evidence supports that the presence of certainmotifs on
miRNAs may facilitate their transfer into EVs (Villarroya-Beltri
et al., 2013; Koppers-Lalic et al., 2014).
Whether miRNA-Ago2 or miRNA-RISC complexes are
present in EVs is of great interest to the EV field. Bound to
Ago2, EV-miRNAs could efficiently assemble into functional
RISCs for downregulation of their mRNA-target in the recipient
cells. Interestingly, the entire RISC was reported to be present
in EVs secreted from cancer cells, leading to efficient and rapid
silencing of mRNA-targets at the recipient cells (Melo et al.,
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2014). An argument against the presence of Ago2 in EVs is
that serum, a typical cell culture additive, contains a significant
amount of non-vesicular Ago2 which may contaminate crude EV
pellets prepared by standard EV isolation techniques, including
ultracentrifugation of the conditioned medium at 100,000 ×
g (Huang et al., 2013). Size exclusion chromatography or
density gradient can be used to separate vesicular from non-
vesicular components of cell culture media (Prieto-Fernández
et al., 2019). Jeppesen et al. (2019) recently used high-resolution
density gradients to separate a crude small EV pellet into
non-vesicular and vesicular fractions. Western blot analysis
revealed that argonauts, including Ago2, were present in both
fractions in media from Gli36 glioblastoma cells, but only in
the non-vesicular fraction of media from DKO1 or MDA-MB-
231 cells. A possible explanation of these findings could be that
both DKO1 and MDA-MB-231 cells carry KRAS mutations.
In contrast to this, several pathogens appear to promote Ago2
trafficking in EVs (Bukong et al., 2014; Mantel et al., 2016).
Therefore, the ability to detect Ago2 in EVs may be a result
of multiple factors, including the cell of origin, experimental
conditions and detectionmethods. TracingmiRNA transfer from
the recipient to the donor cells via EVs would significantly
increase our knowledge on the way that EV-bound miRNAs
affect EC behaviour and therefore, promote neovascularisation
post-cardiac ischaemia. Although, several approaches have been
proposed (reviewed in Mateescu et al., 2017), the detection and
tracing of specific miRNAs in EVs remain challenging due to
several issues, including limited probe specificity, limited signal
per EV and poor signal-to-background ratios.
Currently, interest has been shifted toward engineering EV
surface proteins and cargo for improved targeting (e.g., by the
inclusion of peptides) and functionality. In this way, synthetic
EVs may be loaded with known angiogenic miRNAs and
target ECs to promote neovascularisation. One of the most
common strategies used includes the loading of EV-producing
cells with exogenous miRNAs and the transfection with plasmids
expressing peptides of interest. Thus, EVs derived from these cells
may carry therapeutic miRNAs and express targeting peptides
on their surface. Alternatively, exogenous cargo can be directly
loaded into EVs by several methods, including electroporation,
heat-shock or freeze-thaw procedures, detergent treatment or
sonication (de Abreu et al., 2020). However, further investigation
is needed to define the stoichiometry required for therapeutic
effects observed post-EV-miRNA transfer.
Although the focus of this review is on miRNAs, to date,
several types of non-coding RNAs have emerged as key
regulators of angiogenesis. Long non-coding RNAs (lncRNAs)
for instance, may also control EC proliferation (e.g., MALAT1,
H19, GAS5) or angiogenesis (MEG3, MANTIS) (Kok and
Baker, 2019; Simion et al., 2019). Increasing evidence suggests
that the interactions of lncRNAs with miRNAs play a critical
role in the regulation of angiogenesis (Zhao et al., 2020).
Moreover, lncRNAs may be selectively packaged into EVs
and transferred between cells, improving cardiac function
and vascularisation and reducing fibrosis post-MI (Wu et al.,
2020). Circular RNAs (circRNAs) have also emerged as novel
regulators of EC function and angiogenesis (e.g., CANRIL,
CZNF292, Circ_0010729,Circ_0003575, Circ_0054633,
Circ_0000109) (Zhang and Huang, 2020). CircRNAs can
also be transferred to ECs through EVs. In the context of
post-ischaemic neovascularisation, Dou et al. (2020), showed
that following femoral artery ligation in VSMC specific SIRT1
transgenic (SIRT1-Tg) mice, blood flow and capillary density is
significantly decreased due to the delivery of exosomal cZFP609
from VSMCs to ECs. Interestingly, the authors reported that
cZFP609 may inhibit angiogenesis via blockade of HIF-1a
nuclear translocation and hypoxia-induced VEGF-A expression
in ECs. Integrating knowledge of miRNAs with other non-coding
RNAs and the way that they are transferred between cells will be
critical to our understanding of the biological orchestration that
controls neovascularisation in health and disease.
CONCLUSION
An increasing number of studies have documented the capacity
of EV-bound miRNAs to modulate the angiogenic programs
of ECs and to control neovascularisation following MI. EV
cargo depends on several factors, including the cell source, the
conditions in which EVs have been generated, and the isolation
and purification techniques employed. These factors, along with
the dose used, may determine the beneficial or detrimental
effects of EVs on angiogenesis. EV-based therapeutic approaches,
however, are still challenging since our knowledge of the
mechanisms of miRNA sorting in EVs, EV release, EV-miRNA
uptake and the stoichiometry required for the therapeutic effects
of EV-miRNA treatment is limited. A broader understanding
of these processes, together with the validation of accurate
technologies for the clinical-grade quality control of EVs, would
significantly delineate the benefit-risk balance, and open up new
opportunities for therapeutic strategies.
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